Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
This Symposium followed on our successful 2016 “VirginiaBrainRx” meeting in Richmond, and focused on current challenges and opportunities in drug discovery and development for cancer. The meeting included four keynote addresses from national leaders in the academy, industry and foundations, 20 invited talks from researchers from within the Commonwealth, and over 35 poster presentations.
John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...read more
Professor Rob Gourdie, Director of the Virginia Tech Carilion Research Institute’s (VTCRI) Center for Heart and Regenerative Medicine Research, previously founded First String Research Inc., which is poised to commercialize a treatment for debilitating foot ulcers in...read more
A team headed by Paul Carlier, Professor of Chemistry, Virginia Tech has received funding from the National Institutes of Health to carry out lead optimization on antimalarial drug candidate MMV008138. Carlier, who is Deputy Director of the Virginia Tech Center for...read more
Want to work with us?
If you are interested in supporting this initiative, please contact us.